Publikationen 2009
Seiler S, Heine GH, Fliser D.
Clinical relevance of FGF-23 in chronic kidney disease.
Kidney Int Suppl 2009 Dec(114):S34-42. Impact Punkte: 6,4. Abstract
Pajonk FG, D'Amelio R.
[Suicide and suicidality in emergency medicine].
Anasthesiol Intensivmed Notfallmed Schmerzther 2009 Nov;44(11-12):720-7. Impact Punkte: 0,2. Abstract
Schgoer W, Theurl M, Jeschke J, Beer AG, Albrecht K, Gander R, Rong S, Vasiljevic D, Egger M, Wolf AM, Frauscher S, Koller B, Tancevski I, Patsch JR, Schratzberger P, Piza-Katzer H, Ritsch A, Bahlmann FH, Fischer-Colbrie R, Wolf D, Kirchmair R.
Gene Therapy With the Angiogenic Cytokine Secretoneurin Induces Therapeutic Angiogenesis by a Nitric Oxide-Dependent Mechanism.
Circ Res 2009 Nov 6;105(10):994-1002. Impact Punkte: 10,0. Abstract
Rogacev KS, Ziegelin M, Ulrich C, Seiler S, Girndt M, Fliser D, Heine GH.
Haemodialysis-induced transient CD16+ monocytopenia and cardiovascular outcome.
Nephrol Dial Transplant 2009 Nov;24(11):3480-6. Impact Punkte: 3,6. Abstract
Lonnemann G, Bahlmann FH, Freise J, Hertel B, Dinarello CA.
Low-flux hemodialysis suppresses interferon-gamma production: the possible role of beta2-microglobulin.
Clin Nephrol 2009 Sep;72(3):170-6. Impact Punkte: 1,4. Abstract
Shushakova N, Park JK, Menne J, Fliser D.
Chronic erythropoietin treatment affects different molecular pathways of diabetic cardiomyopathy in mouse.
Eur J Clin Invest 2009 Sep;39(9):755-60. Impact Punkte: 2,8. Abstract
Sester U, Wilkens H, van Bentum K, Singh M, Sybrecht GW, Schafers HJ, Sester M.
Impaired detection of M. tuberculosis immunity upon high levels of immunosuppressive drugs.
Eur Respir J 2009 Sep;34(3):702-10. Impact Punkte: 5,5. Abstract
Presser D, Sester U, Mohrbach J, Janssen M, Kohler H, Sester M.
Differential kinetics of effector and regulatory T cells in patients on calcineurin inhibitor-based drug regimens.
Kidney Int 2009 Sep;76(5):557-66. Impact Punkte: 6,4. Abstract
Ioka T, Tsuruoka S, Ito C, Iwaguro H, Asahara T, Fujimura A, Kusano E.
Hypertension induced by erythropoietin has a correlation with truncated erythropoietin receptor mRNA in endothelial progenitor cells of hemodialysis patients.
Clin Pharmacol Ther 2009 Aug;86(2):154-9. Impact Punkte: 7,6. Abstract
David S, Kumpers P, Lukasz A, Kielstein JT, Haller H, Fliser D.
Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin.
J Hypertens 2009 Aug;27(8):1641-7. Impact Punkte: 5,1. Abstract
Vanholder R, Argiles A, Beige J, Brunet P, Drueke TB, Fliser D, Herget-Rosenthal S, Horl WH, Jorres A, Perna A, Rodriguez-Portillo M, Spasovski G, Stegmayr B, Stenvinkel P, Wanner C, Wiecek A, Massy ZA.
Conservative treatment of the uremic syndrome.
Semin Dial 2009 Jul-Aug;22(4):449-53. Impact Punkte: 2,7. Abstract
Vanholder R, Abou-Deif O, Argiles A, Baurmeister U, Beige J, Brouckaert P, Brunet P, Cohen G, De Deyn PP, Drueke TB, Fliser D, Glorieux G, Herget-Rosenthal S, Horl WH, Jankowski J, Jorres A, Massy ZA, Mischak H, Perna AF, Rodriguez-Portillo JM, Spasovski, Stegmayr BG, Stenvinkel P, Thornalley PJ, Wanner C, Wiecek A.
The role of EUTox in uremic toxin research.
Semin Dial 2009 Jul-Aug;22(4):323-8. Impact Punkte: 2,7. Abstract
Kielstein JT, Fliser D, Veldink H.
Asymmetric dimethylarginine and symmetric dimethylarginine: axis of evil or useful alliance?
Semin Dial 2009 Jul-Aug;22(4):346-50. Impact Punkte: 2,7. Abstract
Faulhaber-Walter R, Hafer C, Jahr N, Vahlbruch J, Hoy L, Haller H, Fliser D, Kielstein JT.
The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit.
Nephrol Dial Transplant 2009 Jul;24(7):2179-86. Impact Punkte: 3,6. Abstract
Bahlmann FH, Fliser D.
The plasticity of progenitor cells--why is it of interest to the nephrologists?
Nephrol Dial Transplant 2009 Jul;24(7):2018-20. Impact Punkte: 3,6. Abstract
Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, Bossink A, Magdorf K, Holscher C, Kampmann B, Arend SM, Detjen A, Bothamley G, Zellweger JP, Milburn H, Diel R, Ravn P, Cobelens F, Cardona PJ, Kan B, Solovic I, Duarte R, Cirillo DM; C. Lange; TBNET.
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement.
Eur Respir J 2009 May;33(5):956-73.Impact Punkte: 5,5. Abstract
Ito C, Akimoto T, Ioka T, Kobayashi T, Kusano E.
TGF-beta inhibits vascular sprouting through TGF-beta type I receptor in the mouse embryonic aorta.
Tohoku J Exp Med 2009 May;218(1):63-71. Impact Punkte: 1,3. Abstract
Schlitt A, Blankenberg S, Bickel C, Lackner KJ, Heine GH, Buerke M, Werdan K, Maegdefessel L, Raaz U, Rupprecht HJ, Munzel T, Jiang XC.
PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene study.
J Lipid Res 2009 Apr;50(4):723-9. Impact Punkte: 4,4. Abstract
Wobrock T, Sittinger H, Behrendt B, D'Amelio R, Falkai P.
Comorbid substance abuse and brain morphology in recent-onset psychosis.
Eur Arch Psychiatry Clin Neurosci 2009 Feb;259(1):28-36. Impact Punkte: 2,9. Abstract
Burkhardt O, Hafer C, Langhoff A, Kaever V, Kumar V, Welte T, Haller H, Fliser D, Kielstein JT.
Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis.
Nephrol Dial Transplant 2009 Jan;24(1):267-71. Impact Punkte: 3,6. Abstract
Bahlmann FH, Fliser D.
Erythropoietin and renoprotection.
Curr Opin Nephrol Hypertens 2009 Jan;18(1):15-20. Impact Punkte: 4,0. Abstract